semaglutide flow study Inclusion and exclusion criteria for the FLOW Trial: Semaglutide Lowers Risk

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in regulating appetite and digestion

They can assess whether the symptoms might be related to semaglutide or other factors. Regular Hearing Assessments: Routine hearing tests can help detect changes early, allowing for timely interventions. Based on current data, hearing loss is not a recognized common side effect of semaglutide

Patients should not attempt to source these agents outside of regulated clinical trial settings

We recommend one per week

[22] Studies have shown that GLP-1 agonists reduce alcohol consumption and alcohol-seeking behavior in rats

Some regain more